FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
13/11/2023
Voltar para busca
Dado oficial do USPTO
THE PHARM BIO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
THE PHARM BIO
ST13
US500000079337447Classe
36, 45
Pedido
79337447
Registro
7088962
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
27
Atualização mais recente
13/11/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
36, 45
Data de depósito
10/09/2021
Data de registro
27/06/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/06/2023
Última transação
27/06/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Parkville VIC 3052, AU
Examinador
JARAMILLO, JAVIER
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
The Pharm Bio Pty Ltd as trustee for The
The Pharm Bio Pty Ltd as trustee for ThePharm Bio Unit Trust
SYNthesis Research Pty Ltd Pharm Bio Unit Trust
Representantes
Neil B. Friedman Hodgson Russ LLP
Classificação técnica
Classes Nice
Classe 36Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 36
Financial services, namely, capital investment; funds management, namely, management of a capital investment fund; venture capital financing; venture capital fund management; investment services, namely, asset acquisition for financial investment; investment of funds for others; commercial property investment services, namely, investment of funds for others in the field of commercial property; capital investment in real estate; trustee services, namely, investment trusteeship; trust investment services, namely, investment and trust company services; investment management; financial investment custody services, namely, maintaining possession of financial assets for others for financial management purposes; financial portfolio management; financial investment fund services, namely, investment of funds for others; trading in stocks; advancement of funds, namely, cash advance services for businesses and merchants; capital investment; financial services, namely, commodity trading for others; financial services, namely, investment asset management; financial services, namely, financial portfolio management; project financing; financing services; financial advisory services; financial consultancy; financial information services; investment advice; financial analysis, namely, investment analysis; providing investment information; financial research, namely, investment research; provision and funding of educational scholarships; advisory and consultancy services relating to the aforementioned services
Classe 45
Licensing of intellectual property rights; legal services related to the exploitation of intellectual property rights; enforcement of intellectual property rights by means of submitting copyright takedown notices for others; advisory services relating to intellectual property rights; legal research relating to intellectual property
Publicações
Histórico de despachos e eventos da marca no USPTO.
27 publicações encontradas
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
28/09/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
28/09/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
27/09/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
27/06/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
27/06/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
24/05/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
19/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/04/2023
PUBO
PUBLISHED FOR OPPOSITION
04/04/2023
CHLD
CHANGE OF OWNER RECEIVED FROM IB
18/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/03/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/02/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/01/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/01/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/01/2023
RFNP
REFUSAL PROCESSED BY IB
23/08/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/08/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29/07/2022
RFRR
REFUSAL PROCESSED BY MPU
28/07/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/07/2022
CNRT
NON-FINAL ACTION WRITTEN
06/07/2022
DOCK
ASSIGNED TO EXAMINER
15/06/2022
MAFR
APPLICATION FILING RECEIPT MAILED
19/04/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/04/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
14/04/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/04/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace THE PHARM BIO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.